Novartis announces NEJM publication of three pivotal trials showing durable and potent efficacy of inclisiran

This article was originally published here

The findings were published in two online articles ahead of print in The New England Journal of Medicine. The primary endpoints were achieved in all three trials. Namely,

The post Novartis announces NEJM publication of three pivotal trials showing durable and potent efficacy of inclisiran appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply